Perigon Wealth Management’s Biogen BIIB Stock Holding History

Perigon Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$493K	Buy	2,182 +421	+24%	+$89.3K	0.01%	916
2026 Q2	$380K	Buy	1,761 +161	+10%	+$30.8K	0.01%	1009
2026 Q1	$293K	Buy	1,600 +98	+7%	+$18.1K	0.01%	1029
2025 Q4	$264K	Buy	+1,502	New	+$245K	﹤0.01%	1072
2023 Q3	–	Sell	-787	Closed	-$224K	–	783
2023 Q2	$224K	Buy	+787	New	+$234K	0.01%	705
2021 Q1	–	Sell	-307	Closed	-$75K	–	546
2020 Q4	$75K	Buy	+307	New	+$79.2K	0.01%	618
2019 Q1	–	Sell	-770	Closed	-$259K	–	223
2018 Q4	$259K	Sell	770 -470	-38%	-$150K	0.07%	174
2018 Q3	$438K	Sell	1,240 -311	-20%	-$107K	0.11%	131
2018 Q2	$450K	Buy	1,551 +570	+58%	+$160K	0.14%	134
2018 Q1	$269K	Buy	981 +942	+2,415%	+$292K	0.1%	140
2017 Q4	$12K	Sell	39 -941	-96%	-$302K	﹤0.01%	471
2017 Q3	$307K	Buy	+980	New	+$290K	0.1%	152
2017 Q2	–	Sell	-34	Closed	-$9K	–	579
2017 Q1	$9K	Buy	34 +10	+42%	+$2.83K	﹤0.01%	531
2016 Q4	$7K	Buy	+24	New	+$7.11K	﹤0.01%	600

Other funds holding BIIB

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Beau Ventures, LLc Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return

Adams Diversified Equity Fund Baltimore, Maryland $3.3B AUM 38.12% 1-Year Est. Return

Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return

North Growth Management Vancouver, British Columbia, Canada $743M AUM 74.29% 1-Year Est. Return

Fideuram - Intesa Sanpaolo Private Banking Turin $3.5B AUM 45.13% 1-Year Est. Return

Perigon Wealth Management's BIIB Position: Q3 2026 in Review

Perigon Wealth Management increased its Biogen (BIIB) stake by 24% in Q3 2026, buying an estimated $89.3K and bringing the position to 2,182 shares worth $493K. The position accounts for 0.01% of the portfolio, ranked #916.

Perigon Wealth Management first reported a position in BIIB in Q4 2016 and has held it in 14 quarters since. 257 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

Perigon Wealth Management held 2,182 shares of Biogen worth $493K as of Q3 2026.
Perigon Wealth Management bought 421 Biogen shares in Q3 2026, an estimated $89.3K.
Biogen made up 0.01% of Perigon Wealth Management's portfolio in Q3 2026, its #916 holding.
Perigon Wealth Management first reported a position in Biogen in Q4 2016 and has held it in 14 quarters since.
257 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Perigon Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.